Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
VT

VTRS

Market Closed

Viatris Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & Generic
US
30.00K employees
CEO: Scott Andrew Smith
Founded: 1980
$20.82
+$0.00(+NaN%)
Market Cap
23.87B
Beta
0.87
52W Range
N/A
Dividend Yield
2.31%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Viatris trades slightly above a $19.32 fair value with a -7.2% implied downside but shows high volatility and a 52.8% downside risk in scenarios below current price. Weak profitability and efficiency scores contrast with moderate liquidity and growth, heightening investment risk. Monte Carlo median at $20.23 suggests pricing near central tendencies amid broad valuation dispersion.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore VTRS

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

VTRS in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →